ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Ankylosing spondylitis (AS) and spondylarthritis"

  • Abstract Number: 2063 • 2018 ACR/ARHP Annual Meeting

    Early Injection of TNF Inhibitor Prevents Spinal Inflammation and Deformity in Curdlan-Induced Spondyloarthritis Animal Model

    Doo-Ho Lim1, Eun-Ju Lee2, Seokchan Hong2, Yong-Gil Kim2, Chang Keun Lee2 and Bin Yoo2, 1Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, Republic of (South)

    Background/Purpose: TNF inhibitors are highly efficient in controlling disease activity and improving functional outcomes as well as quality of life in most ankylosing spondylitis patients;…
  • Abstract Number: 578 • 2017 ACR/ARHP Annual Meeting

    Added Value of Biomarkers Compared to Routine Clinical Parameters for the Prediction of Radiographic Spinal Progression in Axial Spondyloarthritis

    Lorraine Tietz1, Lien Le2, Agnes Hartl1, Martin Rudwaleit1,3, Joachim Sieper1, Ulrich Mansmann2 and Denis Poddubnyy1,4, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Ludwig-Maximilian University, Munich, Germany, 3Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany, 4German Rheumatism Research Centre, Berlin, Germany

    Background/Purpose: Structural damage in the spine is an important determinant of the functional status and spinal mobility in axial spondyloarthritis (axSpA). Already present syndesmophytes, elevated…
  • Abstract Number: 1510 • 2017 ACR/ARHP Annual Meeting

    Similarities and Differences between Osteitis Condensans Ilii and Axial Spondyloarthritis Patients Presenting with Chronic Back Pain in a Rheumatology Setting

    Henning Weineck1, Joachim Listing2, Torsten Diekhoff1, Kay-Geert Hermann1, Joachim Sieper1 and Denis Poddubnyy1,2, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2German Rheumatism Research Centre, Berlin, Germany

    Background/Purpose: Osteitis condensans ilii (OCI) is regarded as a non-inflammatory disorder, which is considered to be induced by mechanical stress (e.g., by pregnancy and delivery).…
  • Abstract Number: 978 • 2015 ACR/ARHP Annual Meeting

    Continuous Versus on Demand Treatment of Ankylosing Spondylitis with Diclofenac over 2 Years Does Not Prevent Radiographic Progression of the Spine: Results from a Randomized Prospective Multi-Center Trial

    Joachim Sieper1, Joachim Listing2, Denis Poddubnyy1, In-Ho Song1,3, Kay-Geert Hermann1, Johanna Callhoff2, Jürgen Braun4 and Martin Rudwaleit1,5, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2German Rheumatism Research Centre, Berlin, Germany, 3Abbvie, Chicago, IL, 4Rheumazentrum Ruhrgebiet, Herne, Germany, 5Klinikum Bielefeld, Bielefeld, Germany

    Background/Purpose: Previously it was shown that non-steroidal antiinflammatory drugs (NSAIDs) given continuously reduce radiographic progression compared to an on demand therapy over 2 years in…
  • Abstract Number: 1730 • 2015 ACR/ARHP Annual Meeting

    Good Control of Inflammation Counterbalances a Negative Impact of Radiographic Spinal Progression on Functional Status and Spinal Mobility in Patients with Ankylosing Spondylitis Treated with TNF Inhibitors

    Denis Poddubnyy1, Aleksandra Fedorova1, Joachim Listing2, Hildrun Haibel1, Xenofon Baraliakos3, Jürgen Braun3 and Joachim Sieper1, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2German Rheumatism Research Centre, Berlin, Germany, 3Rheumazentrum Ruhrgebiet, Herne, Germany

    Background/Purpose: Impaired function and spinal mobility in patients with ankylosing spondylitis (AS) can be caused by both spinal inflammation and new bone formation. Anti-TNF therapy…
  • Abstract Number: 2811 • 2015 ACR/ARHP Annual Meeting

    Higher Serum Level of Leptin Protects from Radiographic Spinal Progression in Patients with Ankylosing Spondylitis

    Agnes Hartl1, Kay-Geert Hermann1, In-Ho Song1,2, Joachim Listing3, Martin Rudwaleit1,4, Joachim Sieper1 and Denis Poddubnyy1, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Abbvie, Chicago, IL, 3German Rheumatism Research Centre, Berlin, Germany, 4Klinikum Bielefeld, Bielefeld, Germany

    Background/Purpose: Fat tissue synthesizes and releases a series of biologically active substances (adipokines), which are involved in bone metabolism through effects on bone formation and…
  • Abstract Number: 2816 • 2015 ACR/ARHP Annual Meeting

    Is the Gender Difference in As Linked to IL-23?

    Johannes Nossent1 and Gunnstein Bakland2,3, 1Medicine, University of Western Australia, WA, Australia, 2Dept. of Rheumatology, University Hospital Northern Norway, Tromsø, Norway, 3University of Tromsø, The Arctic University of Norway, Tromsø, Norway

    Background/Purpose: Ankylosing Spondylitis (AS) has traditionally been portrayed as a disease where male patients outnumber female patients by a factor 3 to 4. It has…
  • Abstract Number: 556 • 2014 ACR/ARHP Annual Meeting

    Defining Flare in Spondyloarthritis : Thresholds of Disease Activity Variations

    Marie Godfrin-Valnet1, Marc Puyraveau2 and Daniel Wendling3, 1Rheumatology, CHRU, Besançon, France, 2Investigation Center, CHRU, Besançon, France, 3Service de Rhumatologie, CHU J Minjoz, Besancon, France

    Background/Purpose: Spondyloarthritis (SpA) activity varies with time and treatment, but to date no clear definition of a flare of the disease is available. The aim…
  • Abstract Number: 551 • 2014 ACR/ARHP Annual Meeting

    Predictors Associated with Rheumatologist Referral Time in Patients with Ankylosing Spondylitis

    Atul A. Deodhar1, Manish Mittal2, Patrick Reilly2, Yanjun Bao2, Shivaji Manthena2, Jaclyn K. Anderson2 and Avani D. Joshi2, 1Oregon Health and Sciences University, Portland, OR, 2AbbVie Inc., North Chicago, IL

    Background/Purpose: Average delay between symptom onset and diagnosis of ankylosing spondylitis (AS) has been reported as 8–12.8 years1,2. This study assessed delay in AS diagnosis…
  • Abstract Number: 40 • 2014 ACR/ARHP Annual Meeting

    Prevalence of Spondyloarthritis (ASAS Criteria) in First-Degree Relatives of Patients with Ankylosing Spondylitis

    Raúl Menor Almagro1, Carmen Ordas2, Carlos Montilla3, Jose Luis Alvarez-Vega4, Íñigo Hernández-Rodríguez5, Montserrat Corteguera6, Santiago MuÑoz Fernandez7, Claudia Urrego8, Rafael Ariza-Ariza9, Mireia Moreno10, Xavier Juanola11, Maria Isabel Tévar12, Eduardo Collantes- Estevez13, Juan Mulero- Mendoza14 and Ana Ruiz-Zorrilla15, 1Rheumatology, Hospital de Jerez, Jerez de la Frontera, Spain, 2Hospital de Cabueñes, Gijón, Spain, 3Rheumatology, Hospital Clínico Universitario de Salamanca, Salamanca, Spain, 4H. de Salamanca, Salamanca, Spain, 5Rheumatology, University Hospital Complex of Vigo, Vigo, Spain, 6Hospital Nª Sª Sonsoles, Avila, Spain, 7Sección de Reumatología, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain, 8Hospital G. Segovia, Segovia, Spain, 9Rheumatology, University Hospital Virgen Macarena, Sevilla, Spain, 10Rheumatology, Hospital Universitari Parc Taulí, Sabadell, Spain, 11Rheumatology, University Hospital Bellvitge, Barcelona, Spain, 12Hospital Vega Baja, Orihuela, Alicante, Spain, 13Hospital Reina Sofía, Córdoba, Spain, 14Hospital Puerta de Hierro, Madrid, Spain, 15Abbvie, Madrid, Spain

    Background/Purpose: Spondyloarthritis (SpA), a group of inflammatory diseases which exhibit similar genetic background, clinical features and symptoms1, has an estimated prevalence of 0.5-1%2 in Spain.…
  • Abstract Number: 2473 • 2013 ACR/ARHP Annual Meeting

    Comparison Of The Two Subtypes Of Axial Spondyloarthritis Patients Fulfilling The Imaging Arm Based On Radiographic and MRI Findings

    Dilek Solmaz, Servet Akar, Ismail Sari, Pinar Cetin, Fatos Onen and Nurullah Akkoc, Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey

    Background/Purpose: New Axial Spondyloarthritis Classification Criteria  include an imaging arm and a clinical arm. The imaging arm includes radiographic ax-SpA patients who have radiographic sacroilitis…
  • Abstract Number: 2472 • 2013 ACR/ARHP Annual Meeting

    Disease Burden Is Similar Between Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis and Independent Of Gender Influences

    Salih Ozgocmen1, Erkan Kilic2, Gamze Kilic2 and Ozgur Akgul2, 1Division of Rheumatology, Dept.PRM, Erciyes University, Faculty of Medicine, Kayseri, Turkey, 2Division of Rheumatology, Dept. PRM, Erciyes University, Faculty of Medicine, Kayseri, Turkey

    Disease Burden is Similar between Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis and Independent of Gender Influences Background/Purpose: Axial spondyloarthritis (SpA) covers both ankylosing spondylitis (AS)…
  • Abstract Number: 2437 • 2013 ACR/ARHP Annual Meeting

    Prevalence Of Axial Spondyloarthritis In The United States Among Patients With Chronic Back Pain and Other Spondyloarthritis-Related Features

    Atul A. Deodhar1, Philip J. Mease2, Jeffrey R. Curtis3, Piyalal M. Karunaratne4, Kailash Malhotra4 and Aileen L. Pangan4, 1Oregon Health & Science University, Portland, OR, 2University of Washington and Swedish Medical Center, Seattle, WA, 3University of Alabama at Birmingham, Birmingham, AL, 4AbbVie Inc., North Chicago, IL

    Background/Purpose: The age-adjusted prevalence of spondyloarthritis (SpA) has been estimated to be 0.9-1.4% of the US population using the Amor and ESSG criteria. The objective…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology